Format

Send to

Choose Destination
Breast J. 2015 Mar-Apr;21(2):181-4. doi: 10.1111/tbj.12375. Epub 2015 Feb 23.

Intraoperative radiotherapy of the breast for early-stage breast cancer: ready for primetime.

Author information

1
Los Angeles Center for Women's Health, Los Angeles, California.

Abstract

The findings of the TARGIT A and ELIOT prospective, randomized controlled trials provide compelling data regarding the efficacy and safety of single fraction intraoperative radiotherapy as an alternative to standard postoperative radiotherapy in the management of early-stage breast cancer. This editorial summarizes the findings of both studies and discusses the importance of patient selection in identifying potential candidates for intraoperative radiotherapy.

KEYWORDS:

ELIOT; IORT; TARGIT; breast cancer; intraoperative radiotherapy

PMID:
25703933
DOI:
10.1111/tbj.12375
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center